Standard Life Aberdeen »

Quoin Pharmaceuticals shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Quoin Pharmaceuticals (QNRX) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Quoin Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Quoin Pharmaceuticals held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quoin Pharmaceuticals by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 75k 14.43

More positions owned by Standard Life Aberdeen

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
Abbvie (ABBV)
Mastercard Incorporated Cl A (MA)

View all positions for Standard Life Aberdeen

Top funds holding Quoin Pharmaceuticals

Ikarian Capital
Woodline Partners
Stonepine Capital Management
Standard Life Aberdeen
Millennium Management
SummitTX Capital
Boothbay Fund Management
ADAR1 Capital Management
AIGH Capital Management
Resolute Capital Asset Partners
Soleus Capital Management
Simplify Asset Management
Centiva Capital
GAMMA Investing
Rhumbline Advisers

View all funds holding Quoin Pharmaceuticals